These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1517015)

  • 41. Refinement of conformational preferences of Leu enkephalin and Tyr-Gly-Gly-Phe by 15N n.m.r.: chemical shifts and vicinal coupling constants.
    Garbay-Jaureguiberry C; Marion D; Fellion E; Roques BP
    Int J Pept Protein Res; 1982 Nov; 20(5):443-50. PubMed ID: 7174208
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thermodynamic origin of cis/trans isomers of a proline-containing beta-turn model dipeptide in aqueous solution: a combined variable temperature 1H-NMR, two-dimensional 1H,1H gradient enhanced nuclear Overhauser effect spectroscopy (NOESY), one-dimensional steady-state intermolecular 13C,1H NOE, and molecular dynamics study.
    Troganis A; Gerothanassis IP; Athanassiou Z; Mavromoustakos T; Hawkes GE; Sakarellos C
    Biopolymers; 2000 Jan; 53(1):72-83. PubMed ID: 10644952
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyclic and acyclic partial retro-inverso enkephalinamides: Mu receptor selective enzyme resistant analogs.
    Berman JM; Goodman M; Nguyen TM; Schiller PW
    Biochem Biophys Res Commun; 1983 Sep; 115(3):864-70. PubMed ID: 6312999
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Maximum entropy approach to the determination of solution conformation of flexible polypeptides by global conformational analysis and NMR spectroscopy--application to DNS1-c-[D-A2,bu2,Trp4,Leu5]enkephalin and DNS1-c-[D-A2bu2,Trp4,D-Leu5]enkephalin.
    Groth M; Malicka J; Czaplewski C; Ołdziej S; Lankiewicz L; Wiczk W; Liwo A
    J Biomol NMR; 1999 Dec; 15(4):315-30. PubMed ID: 10685340
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dermorphin tetra- and heptapeptide analogues containing a [3,4] amide bond replacement by a carbon-carbon double and single bond.
    Jaspers H; Tourwé D; van Binst G; Pepermans H; Borea P; Ucelli L; Salvadori S
    Int J Pept Protein Res; 1992 Apr; 39(4):315-21. PubMed ID: 1428522
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of NMR and fluorescence spectroscopy as well as theoretical conformational analysis in conformation-activity studies of cyclic enkephalin analogues.
    Malicka J; Czaplewski C; Groth M; Wiczk W; Oldziej S; Lankiewicz L; Ciarkowski J; Liwo A
    Curr Top Med Chem; 2004; 4(1):123-33. PubMed ID: 14754380
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of the solution conformations of a human immunodeficiency virus peptidomimetic and its retro-inverso isomer using 1H NMR spectroscopy.
    Higgins KA; Bicknell W; Keah HH; Hearn MT
    J Pept Res; 1997 Dec; 50(6):421-35. PubMed ID: 9440043
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular dynamics simulations of opioid peptide analogs containing multiple conformational restrictions.
    Wilkes BC; Schiller PW
    Int J Pept Protein Res; 1992; 40(3-4):249-54. PubMed ID: 1478782
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conformational characteristics of receptor-selective opioid peptides. 1H n.m.r. and c.d. spectroscopic studies of delta-kephalin and [Val4]morphiceptin.
    Doi M; Tanaka M; Ikuma K; Nabae M; Kitamura K; Inoue M; Ishida T
    Biochem J; 1988 Apr; 251(2):581-8. PubMed ID: 2840898
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 270-MHz 1H nuclear-magnetic-resonance study of met-enkephalin in solvent mixtures. Conformational transition from dimethylsulphoxide to water.
    Zetta L; Cabassi F
    Eur J Biochem; 1982 Feb; 122(1):215-22. PubMed ID: 7060566
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties.
    Schmidt R; Wilkes BC; Chung NN; Lemieux C; Schiller PW
    Int J Pept Protein Res; 1996 Nov; 48(5):411-9. PubMed ID: 8956074
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The mu-selective heptapeptide opioid dermorphin has two conformations around Phe3 psi with no head-to-tail interaction. A quantitative 2-D NMR and molecular modeling analysis.
    Riand J; Nicolas P; Baron D
    J Biomol Struct Dyn; 2002 Dec; 20(3):359-73. PubMed ID: 12437374
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Conformational comparison of mu-selective endomorphin-2 with its C-terminal free acid in DMSO solution, by 1H NMR spectroscopy and molecular modeling calculation.
    In Y; Minoura K; Ohishi H; Minakata H; Kamigauchi M; Sugiura M; Ishida T
    J Pept Res; 2001 Nov; 58(5):399-412. PubMed ID: 11892849
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Opioid activity of dermenkephalin analogues in the guinea-pig myenteric plexus and the hamster vas deferens.
    Sagan S; Corbett AD; Amiche M; Delfour A; Nicolas P; Kosterlitz HW
    Br J Pharmacol; 1991 Oct; 104(2):428-32. PubMed ID: 1665735
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Morphiceptin and beta-casomorphin-5 analogues containing a reduced peptide bond: selective mu-receptor agonists and a novel mu antagonist, H-Tyr-Pro psi (CH2-NH)Phe-Pro-Gly-OH.
    Delaet NG; Verheyden PM; Tourwe D; Van Binst G; Davis P; Burks TF
    Biopolymers; 1992 Aug; 32(8):957-69. PubMed ID: 1330047
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Conformationally restricted deltorphin analogues.
    Schiller PW; Weltrowska G; Nguyen TM; Wilkes BC; Chung NN; Lemieux C
    J Med Chem; 1992 Oct; 35(21):3956-61. PubMed ID: 1331451
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Conversion of enkephalin and dermorphin into delta-selective opioid antagonists by single-residue substitution.
    Tancredi T; Salvadori S; Amodeo P; Picone D; Lazarus LH; Bryant SD; Guerrini R; Marzola G; Temussi PA
    Eur J Biochem; 1994 Aug; 224(1):241-7. PubMed ID: 8076645
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ni-to-Ni+ 3-ethylene-bridged partially modified retro-inverso tetrapeptide beta-turn mimetic: design, synthesis, and structural characterization.
    Han Y; Giragossian C; Mierke DF; Chorev M
    J Org Chem; 2002 Jul; 67(15):5085-97. PubMed ID: 12126392
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Topochemical analysis of morphiceptin and dermorphin bioactivities.
    Yamazaki T; Ro S; Goodman M
    Biochem Biophys Res Commun; 1991 Dec; 181(2):664-70. PubMed ID: 1661586
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and receptor binding analysis of dermorphin hepta-, hexa- and pentapeptide analogues. Evidence for one- and two-side binding models for the mu-opioid receptor.
    Attila M; Salvadori S; Balboni G; Bryant SD; Lazarus LH
    Int J Pept Protein Res; 1993 Dec; 42(6):550-9. PubMed ID: 7905867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.